The fourth dose: My "me-first" experience

Creative Commons License

Ahmed F.

Indian journal of medical ethics, vol.VII, no.3, pp.237-239, 2022 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: VII Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.20529/ijme.2022.010
  • Journal Name: Indian journal of medical ethics
  • Journal Indexes: Scopus, EMBASE, MEDLINE, Philosopher's Index
  • Page Numbers: pp.237-239
  • Ankara Yıldırım Beyazıt University Affiliated: Yes


Vaccine inequality is the biggest obstacle to curbing the Covid-19 pandemic and accelerating socio-economic recovery in the developing countries. Many people, including myself, living in developing countries, were initially inoculated with the WHO-approved vaccines unwelcome to developed countries, such as Sinovac. Presently, governments in developing countries are offering the third and fourth doses of mRNA vaccines to facilitate cross-border travel. This creates a devastating burden on ongoing Covid-19 vaccination in developing countries, increasing the injustice and inequality between the developed and developing countries. Here, I share my thoughts as a public health specialist while I was receiving the fourth dose of the Covid-19 vaccine to fulfil travel requirements.